Ossiam Has $1.08 Million Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Ossiam raised its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 52.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 115,662 shares of the pharmacy operator's stock after buying an additional 39,578 shares during the period. Ossiam's holdings in Walgreens Boots Alliance were worth $1,079,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of WBA. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at $946,000. Dimensional Fund Advisors LP lifted its stake in shares of Walgreens Boots Alliance by 17.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,823,924 shares of the pharmacy operator's stock valued at $17,016,000 after acquiring an additional 272,895 shares during the period. First Trust Advisors LP acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at $368,000. Forum Financial Management LP lifted its stake in shares of Walgreens Boots Alliance by 71.2% during the fourth quarter. Forum Financial Management LP now owns 19,725 shares of the pharmacy operator's stock valued at $184,000 after acquiring an additional 8,206 shares during the period. Finally, GeoWealth Management LLC lifted its stake in shares of Walgreens Boots Alliance by 121.4% during the fourth quarter. GeoWealth Management LLC now owns 26,520 shares of the pharmacy operator's stock valued at $247,000 after acquiring an additional 14,541 shares during the period. Institutional investors and hedge funds own 58.59% of the company's stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA traded down $0.02 during midday trading on Friday, hitting $11.01. 6,349,910 shares of the company's stock were exchanged, compared to its average volume of 21,083,041. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $18.83. The company's 50 day moving average price is $10.95 and its 200 day moving average price is $10.22. The firm has a market capitalization of $9.52 billion, a PE ratio of -1.08, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $38.59 billion during the quarter, compared to the consensus estimate of $37.90 billion. During the same period in the previous year, the company posted $1.20 EPS. The firm's revenue for the quarter was up 4.1% compared to the same quarter last year. As a group, analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on WBA shares. StockNews.com started coverage on Walgreens Boots Alliance in a research note on Sunday. They set a "hold" rating on the stock. Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a report on Friday, January 31st. Evercore ISI increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a report on Monday, January 13th. Bank of America increased their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a report on Monday, January 13th. Finally, Royal Bank of Canada increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a report on Wednesday, January 15th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Walgreens Boots Alliance has a consensus rating of "Hold" and an average target price of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.